Date/Time
Date(s) - Sep 17, 2015 - Sep 18, 2015
All Day
Location
Carlsberg Museum & Business Centre in Copenhagen
Categories
Language English
Changing times ask for solid relationships.
Times are changing. A renewed interest from big pharma in the rare disease landscape has awakened due to large-scale patent expirations, competition from generics & biosimilars, anemic pipelines, escalating clinical trial costs and a global health-care reform. This means that the traditional blockbuster model has become less viable while the revenue-generating potential of orphan drugs has shown to be huge with a greater return on investment than non-orphan drugs. According to EvaluatePharma, the orphan drugs sales will grow at an annual rate of 11% and constitute 19% of the total share of prescription drugs by 2020, totalling 176 billion dollars.
The rare disease landscape is very complex due to the large amount of stakeholders involved. Despite their different interests they have one goal in common: getting an orphan drug approval that will help save or improve lives. But there are many challenges on the road to orphan drug designation:
Complex and changing national and regional regulations
Clinical trial design and finding & keeping patients
The lack of a central database designed specifically to list patient registries, which asks for close stakeholder engagement
Partnering and establishing financing for future development
Establishing a foundation for price that is balanced and sustainable
Achieving an efficient and timely access to market with equal access for patients around the world
Achieving timely and correct diagnosis to enable higher quality of life and more time and information for developers
Changing environments ask for a changing conference. With the help of the audience we have been able to map the complex orphan drugs ecosystem, resulting in a whole new concept at the Orphan Drugs Summit 2015. This conference is specifically designed to enable future stakeholder interactions, which is much needed. Each session brings together different groups of stakeholders on specifically selected topics to help them build relationships and reach their goals. With the right relations and the right discussions we can help shape the future of healthcare by collaboration.
Flip the pages to see your ecosystem map and what sessions are specially designed for you. Start building your solid relationships right here, right now!
Welcome to the 5th annual Orphan Drugs Summit.
Read more here
